Sprint Interval Training for Spinal Cord Injury
(SIT Trial)
Trial Summary
What is the purpose of this trial?
This study will assess the feasibility and efficacy of 3 treatments to increase physical activity during and after inpatient rehabilitation (IPR) for new spinal cord injuries: 1. Program of sprint interval training (SIT) on an arm crank ergometer during IPR 2. SIT + Provision of an arm ergometer (ERGO) for home use 3. SIT + ERGO for home use + Motivational interviewing to increase adherence to exercise during and after IPR. The primary outcome is minutes per week of moderate to vigorous physical activity at 6 months after IPR discharge. Secondary outcomes include peak power on the 6-Minute Arm Test at IPR discharge and self-reported physical activity, depression, fatigue, pain, community participation, and quality of life at 6 months after IPR discharge. The investigators will obtain data on feasibility, acceptability, and perceived benefits of the treatments from stakeholders. The results of this pilot study will inform the design of a larger randomized trial.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Home Ergometer (ERGO), Motivational Interviewing (MI), Sprint Interval Training (SIT) for spinal cord injury?
Research shows that regular interval training on a seated ergometer can safely increase physical capacity in individuals with spinal cord injury, suggesting that similar methods like Sprint Interval Training (SIT) could be effective. Additionally, long-term exercise training has been shown to improve strength and psychological well-being in people with spinal cord injury, supporting the potential benefits of this treatment approach.12345
Is Sprint Interval Training safe for people with spinal cord injuries?
The studies reviewed focus on high-intensity interval training (HIIT) for people with spinal cord injuries, assessing its feasibility and health benefits. While they do not specifically address safety, the research implies that HIIT, which includes sprint interval training, is being actively studied for this population, suggesting a level of safety that allows for such trials.678910
How does Sprint Interval Training (SIT) differ from other treatments for spinal cord injury?
Sprint Interval Training (SIT) is unique because it involves short bursts of high-intensity exercise that can improve both aerobic and anaerobic performance, which is different from traditional rehabilitation exercises that may focus more on steady, moderate activity. This approach can enhance peak speed and oxygen uptake, offering a novel way to potentially improve physical capacity in individuals with spinal cord injury.1112131415
Research Team
Deborah A Crane, MD, MPH
Principal Investigator
University of Washington
Eligibility Criteria
Adults aged 18-65 with a new spinal cord injury (SCI) below the C2 vertebra, classified as AIS A-C, who are currently in acute inpatient rehabilitation at Harborview Medical Center and can use an arm ergometer. Excluded are those with shoulder injuries, other conditions preventing safe participation, uncontrolled diabetes type II, or unstable heart disease.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Inpatient Rehabilitation
Participants undergo Sprint Interval Training (SIT) approximately three times per week during inpatient rehabilitation
Post-Discharge Home Exercise
Participants continue SIT at home using a consumer grade ergometer, with motivational interviewing sessions provided monthly
Follow-up
Participants are monitored for physical activity and other outcomes at 6 months post-discharge
Treatment Details
Interventions
- Home Ergometer (ERGO)
- Motivational Interviewing (MI)
- Sprint Interval Training (SIT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
The Craig H. Neilsen Foundation
Collaborator